Record added: Dec. 1, 2016, 10:34 a.m.
Record updated: Sept. 30, 2019, 2:18 p.m. by The FAIRsharing Team.

Edits to 'https://fairsharing.org/FAIRsharing.3f9n4y' by 'The FAIRsharing Team' at 14:18, 30 Sep 2019 (approved):

	'organizations' has been modified:
		Before:
			European Commission under FP7 Grant Agreement|http://ec.europa.eu/research/fp7/index_en.cfm?pg=documents|Undefined
			BioGen|https://www.biogen.com/|Maintains
			GlaxoSmithKline|http://www.gsk.com|Funds
			The Wellcome Trust Sanger Institute, The Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK|http://www.sanger.ac.uk|Maintains
		After:
			GlaxoSmithKline|http://www.gsk.com|Funds
			BioGen|https://www.biogen.com/|Maintains
			The Wellcome Trust Sanger Institute, The Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK|http://www.sanger.ac.uk|Maintains
			European Commission under FP7 Grant Agreement|http://ec.europa.eu/research/fp7/index_en.cfm?pg=documents|Funds
		Added:
			European Commission under FP7 Grant Agreement|http://ec.europa.eu/research/fp7/index_en.cfm?pg=documents|Funds
		Removed:
			European Commission under FP7 Grant Agreement|http://ec.europa.eu/research/fp7/index_en.cfm?pg=documents|Undefined

	'related_databases' has been modified:
		Before:
			ChEMBL
			Expression Atlas
			Reactome - a curated knowledgebase of biological pathways
			UniProt Knowledgebase
		After:
			ChEMBL
			Expression Atlas
			Europe PubMed Central
			Reactome - a curated knowledgebase of biological pathways
			UniProt Knowledgebase
			European Variation Archive
			Genome-Wide Association Studies Catalog
		Added:
			Europe PubMed Central
			European Variation Archive
			Genome-Wide Association Studies Catalog
		Removed:

	'supportLinks' has been modified:
		Before:
			FAQ|https://www.targetvalidation.org/faq
			email|support@targetvalidation.org
			online documentation|https://www.targetvalidation.org/about
			online documentation|https://www.targetvalidation.org/documentation/api
			training|https://www.targetvalidation.org/outreach
			twitter|@targetvalidate
		After:
			FAQ|https://docs.targetvalidation.org/faq/frequently-asked-questions
			blog|http://blog.opentargets.org/
			help|https://docs.targetvalidation.org/
			online documentation|https://www.targetvalidation.org/about
			tess training|https://tess.elixir-europe.org/materials/text-mining-key-concepts-and-applications
			tess training|https://tess.elixir-europe.org/materials/open-targets-using-genetics-and-functional-genomics-to-identify-and-prioritise-targets-for-new-medicines
			training|https://www.targetvalidation.org/outreach
			twitter|@targetvalidate
		Added:
			FAQ|https://docs.targetvalidation.org/faq/frequently-asked-questions
			blog|http://blog.opentargets.org/
			help|https://docs.targetvalidation.org/
			tess training|https://tess.elixir-europe.org/materials/text-mining-key-concepts-and-applications
			tess training|https://tess.elixir-europe.org/materials/open-targets-using-genetics-and-functional-genomics-to-identify-and-prioritise-targets-for-new-medicines
		Removed:
			FAQ|https://www.targetvalidation.org/faq
			email|support@targetvalidation.org
			online documentation|https://www.targetvalidation.org/documentation/api

	'description' has been modified:
		Before: Open Targets designed and developed an integration and visualization platform that provides evidence about the association of known and potential drug targets with diseases. The platform is designed to support identification and prioritization of biological targets for follow-up. Each drug target is linked to a disease using integrated genome-wide data from a broad range of data sources. The platform provides either a target-centric workflow to identify diseases that may be associated with a specific target, or a disease-centric workflow to identify targets that may be associated with a specific disease. Users can easily transition between these target- and disease-centric workflows. 
		After: Open Targets is a data integration platform for access to and visualisation of potential drug targets associated with disease. Each drug target is linked to a disease using integrated genome-wide data from a broad range of data sources.

	'countries' has been modified:
		Before:
			United Kingdom
			United States
		After:
			China
			United Kingdom
			United States
		Added:
			China
		Removed:

	'licences' has been modified:
		Before:
		After:
			Open Target Terms of Use|https://www.targetvalidation.org/terms-of-use|Data
		Added:
			Open Target Terms of Use|https://www.targetvalidation.org/terms-of-use|Data
		Removed:

	'dataProcesses' has been modified:
		Before:
		After:
			Download
		Added:
			Download
		Removed:

	'contactEmail' has been modified:
		Before: contact@opentargets.org
		After: support@targetvalidation.org

	'user_defined_tags' has been modified:
		Before:
			Approved drug
			Drug Target
			Mode of action
			Validation
		After:
			Approved drug
		Added:
		Removed:
			Drug Target
			Mode of action
			Validation

	'contact' has been modified:
		Before: Open Targets core team
		After: Open Targets Team

	'miriam_id' has been modified:
		Before: None
		After: 

	'publications' has been modified:
		Before:
			Open Targets: a platform for therapeutic target identification and validation.|Koscielny G,An P,Carvalho-Silva D,Cham JA,Fumis L,Gasparyan R,Hasan S,Karamanis N,Maguire M,Papa E,Pierleoni A,Pignatelli M,Platt T,Rowland F,Wankar P,Bento AP,Burdett T,Fabregat A,Forbes S,Gaulton A,Gonzalez CY,Hermjakob H,Hersey A,Jupe S,Kafkas S,Keays M,Leroy C,Lopez FJ,Magarinos MP,Malone J,McEntyre J,Munoz-Pomer Fuentes A,O'Donovan C,Papatheodorou I,Parkinson H,Palka B,Paschall J,Petryszak R,Pratanwanich N,Sarntivijal S,Saunders G,Sidiropoulos K,Smith T,Sondka Z,Stegle O,Tang YA,Turner E,Vaughan B,Vrousgou O,Watkins X,Martin MJ,Sanseau P,Vamathevan J,Birney E,Barrett J,Dunham I|Nucleic Acids Res|2016
		After:
			Open Targets: a platform for therapeutic target identification and validation.|Koscielny G,An P,Carvalho-Silva D,Cham JA,Fumis L,Gasparyan R,Hasan S,Karamanis N,Maguire M,Papa E,Pierleoni A,Pignatelli M,Platt T,Rowland F,Wankar P,Bento AP,Burdett T,Fabregat A,Forbes S,Gaulton A,Gonzalez CY,Hermjakob H,Hersey A,Jupe S,Kafkas S,Keays M,Leroy C,Lopez FJ,Magarinos MP,Malone J,McEntyre J,Munoz-Pomer Fuentes A,O'Donovan C,Papatheodorou I,Parkinson H,Palka B,Paschall J,Petryszak R,Pratanwanich N,Sarntivijal S,Saunders G,Sidiropoulos K,Smith T,Sondka Z,Stegle O,Tang YA,Turner E,Vaughan B,Vrousgou O,Watkins X,Martin MJ,Sanseau P,Vamathevan J,Birney E,Barrett J,Dunham I|Nucleic Acids Res|2016
			Open Targets Platform: new developments and updates two years on.|Carvalho-Silva D,Pierleoni A,Pignatelli M,Ong C,Fumis L,Karamanis N,Carmona M,Faulconbridge A,Hercules A,McAuley E,Miranda A,Peat G,Spitzer M,Barrett J,Hulcoop DG,Papa E,Koscielny G,Dunham I|Nucleic Acids Res|2018
		Added:
			Open Targets Platform: new developments and updates two years on.|Carvalho-Silva D,Pierleoni A,Pignatelli M,Ong C,Fumis L,Karamanis N,Carmona M,Faulconbridge A,Hercules A,McAuley E,Miranda A,Peat G,Spitzer M,Barrett J,Hulcoop DG,Papa E,Koscielny G,Dunham I|Nucleic Acids Res|2018
		Removed:

	'accessPoints' has been modified:
		Before:
			REST|https://www.targetvalidation.org/api/latest/|The Target Validation Platform API ('Application Programming Interface') allows programmatic retrieval of our data (evidence, asssociation, targets, diseases) via a set of REST services.
		After:
			REST|https://docs.targetvalidation.org/tutorials/rest-api|Open Targets Platform API
		Added:
			REST|https://docs.targetvalidation.org/tutorials/rest-api|Open Targets Platform API
		Removed:
			REST|https://www.targetvalidation.org/api/latest/|The Target Validation Platform API ('Application Programming Interface') allows programmatic retrieval of our data (evidence, asssociation, targets, diseases) via a set of REST services.

	'contactORCID' has been modified:
		Before: 0000-0002-6315-0263
		After: 

            

Edits to 'https://fairsharing.org/FAIRsharing.3f9n4y' by 'The FAIRsharing Team' at 12:40, 14 Dec 2016 (approved):

	'shortname' has been modified:
		Before: Open Targets
		After:  Domain list has changed:  Previous values: Approved drugs|| Disease Ontology|| Disease model|process| Epigenetics|| Gene annotation relevant to drug discovery|| Gene-disease relationships|| Genetics|process|http://ontology.neuinfo.org/NIF/DigitalEntities/NIF-Scientific-Discipline.owl#nlx_inv_100628 Genomics|| Human disease|x| Literature abstracts|| Molecular Biology|None| Phenotype|information content entity|http://ontology.neuinfo.org/NIF/DigitalEntities/NIF-Investigation.owl#birnlex_2087 Phenotype and disease association|| Rare disease|None| Target Validation Information|| Target therapeutic class|| Text mining|| Transcriptomics|| drug mode of action|None| drug targets|None| human genetics database|None| New values:  Approved drugs|| Disease Ontology|| Disease model|process| Epigenetics|| Gene annotation relevant to drug discovery|| Gene-disease relationships|| Genetics|process|http://ontology.neuinfo.org/NIF/DigitalEntities/NIF-Scientific-Discipline.owl#nlx_inv_100628 Genomics|| Human disease|x| Literature abstracts|| Molecular Biology|None| Phenotype|information content entity|http://ontology.neuinfo.org/NIF/DigitalEntities/NIF-Investigation.owl#birnlex_2087 Phenotype and disease association|| Rare disease|None| Target Validation Information|| Target therapeutic class|| Text mining|| Transcriptomics|| drug mode of action|None| drug targets|None| human genetics database|None| Biomedical Science|None| Countries have changed:  Previous values: New values:  United Kingdom United States of America Publication List has changed:  Previous values: New values:  Open Targets: a platform for therapeutic target identification and validation.